Cutaneous lupus skin disease registry study
Part of Immune system & allergy, Skin clinical trials.
This study builds a registry (a protected medical record) of people with cutaneous lupus and/or systemic lupus that affects the skin. It gathers skin exam information and may include a skin biopsy and blood tests to better understand these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lupus affecting the skin (cutaneous lupus) and/or lupus affecting the body (systemic lupus).
- You can speak and read English or Spanish (about a 6th-grade reading level).
- You are able and willing to sign written informed consent to join the study.
- You are 18 years or older.
- Your skin biopsy and any blood tests are medically appropriate for you (your clinician says it’s safe/needed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a registry for people with lupus and their families. It helps researchers learn more about lupus and improve care. You or your child can join if you have a lupus diagnosis.
This trial is a registry that follows people with lupus to help Duke researchers learn about the disease and care. You may be able to join if you’re seen by a Duke rheumatologist and can come to follow-up visits.
This study creates a registry for people with systemic lupus erythematosus (SLE) to track the disease over time. Joining helps researchers learn more about lupus and may improve care for future patients.
This study keeps a long-term record of people with lupus (systemic lupus erythematosus) and collects samples so researchers can study the disease better. You may be able to join if you meet lupus diagnosis criteria, are not pregnant, and can follow the study visits and consent process.
This is a registry that follows adults with newly diagnosed lupus (within 5 years) to better understand the disease and care needs over time. It may help researchers and doctors learn what to expect early in lupus and improve future treatment planning.
This registry tracks the safety and effectiveness of lupus treatments over time. If you have SLE and are starting a new treatment or were recently diagnosed, joining helps doctors learn which medicines work best.
Hear when a new Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.